Uncovering an Enzymatic Program that Drives Physiological and Pathological Amyloid Formation.

发现驱动生理和病理淀粉样蛋白形成的酶程序。

基本信息

  • 批准号:
    10571966
  • 负责人:
  • 金额:
    $ 9.34万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-01-01 至 2024-12-31
  • 项目状态:
    已结题

项目摘要

Project Summary Amyloids are β-sheet rich aggregates that accumulate in various proteinopathies. This correlation has led to the association of amyloids with the diseased state. However, organisms across biology utilize amyloids without any apparent detrimental effects. This raises the fundamental question; how do cells assemble non-toxic amyloids as needed? Our lab uncovered an inducible program of physiological amyloidogenesis that converts Nucleoli into Amyloid-bodies. While investigating these amyloid-enriched, solid-like condensates, we identified that Terminal End Nucleotidyltransferase 4b (TENT4b) stimulated the conversion of amyloidogenic liquid-to-solid phase transition. Our preliminary results indicate that TENTs catalyze unusually long poly(A)-rich tails to drive amyloidogenesis. These low-complexity RNA molecules act as linear polyanionic cofactors that stimulate amyloidogenesis. This activity is inhibited by the RNA exosome which degrades tailed RNA. In addition to physiological amyloidogenesis, TENTs also catalyze pathological amyloidogenesis which exhausts toxic oligomeric intermediates in Alzheimer’s and Parkinson’s disease models. Depletion of the RNA exosome that antagonizes TENTs, delays age-associated proteotoxicity in these disease models. These results suggest the following hypothesis for this K99:R00 application: The RNA tailing machinery drives amyloidogenesis to protect against toxic oligomeric intermediates. We plan to test this hypothesis by: Aim 1- investigating the mechanism that drives physiological amyloidogenesis and Aim 2- testing if this machinery protects against pathological amyloid toxicity. This research program reveals the provocative concept that cells possess enzymes dedicated to making non-toxic amyloids, highlighting that cellular amyloidogenesis is an actively controlled process. The cellular use of RNA to actively control protein folding bridges unrelated fields of research and offers new approaches to combat amyloid based disease.
项目摘要 淀粉样蛋白是一种富含β片状的聚集体,在各种蛋白质病中积聚。这种相关性导致了 淀粉样蛋白与疾病状态的关系。然而,整个生物界的生物利用淀粉样蛋白,而不是任何 明显的有害影响。这就提出了一个根本问题:细胞如何组装无毒的淀粉样蛋白? 根据需要?我们的实验室发现了一种可诱导的生理性淀粉样蛋白发生程序,可将核仁转化为 变成淀粉样体。在研究这些富含淀粉样物质的固体状凝聚体时,我们发现 末端核苷酸转移酶4b(TENT4b)促进淀粉样变性液体向固体转化 相变。我们的初步结果表明,帐篷催化异常长的富含聚(A)的尾巴推动 淀粉样变。这些低复杂性的RNA分子充当线性多阴离子辅助因子,刺激 淀粉样变。这种活性被降解拖尾RNA的RNA外体抑制。除了……之外 生理性淀粉样变,帐篷也催化病理性淀粉样变,从而耗尽有毒物质 阿尔茨海默病和帕金森氏病模型中的寡聚中间体。耗尽RNA外切体 对抗帐篷,延缓这些疾病模型中与年龄相关的蛋白毒性。这些结果表明, 以下为K99:R00应用的假设:RNA拖尾机制驱动淀粉样蛋白发生保护 对抗有毒的低聚中间体。我们计划通过以下方式检验这一假设:目标1--研究机制 这推动了生理性淀粉样蛋白的发生和AIM 2-测试这一机制是否能防止病理性 淀粉样蛋白毒性。这项研究计划揭示了一个具有挑衅性的概念,即细胞拥有专门用于 到制造无毒的淀粉样蛋白,强调细胞淀粉样蛋白的发生是一个主动控制的过程。这个 细胞使用RNA来主动控制蛋白质折叠,为无关的研究领域架起了桥梁,并提供了新的 对抗基于淀粉样蛋白的疾病的方法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Michael Bokros其他文献

Michael Bokros的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

Interplay between Aging and Tubulin Posttranslational Modifications
衰老与微管蛋白翻译后修饰之间的相互作用
  • 批准号:
    24K18114
  • 财政年份:
    2024
  • 资助金额:
    $ 9.34万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
EMNANDI: Advanced Characterisation and Aging of Compostable Bioplastics for Automotive Applications
EMNANDI:汽车应用可堆肥生物塑料的高级表征和老化
  • 批准号:
    10089306
  • 财政年份:
    2024
  • 资助金额:
    $ 9.34万
  • 项目类别:
    Collaborative R&D
The Canadian Brain Health and Cognitive Impairment in Aging Knowledge Mobilization Hub: Sharing Stories of Research
加拿大大脑健康和老龄化认知障碍知识动员中心:分享研究故事
  • 批准号:
    498288
  • 财政年份:
    2024
  • 资助金额:
    $ 9.34万
  • 项目类别:
    Operating Grants
Baycrest Academy for Research and Education Summer Program in Aging (SPA): Strengthening research competencies, cultivating empathy, building interprofessional networks and skills, and fostering innovation among the next generation of healthcare workers t
Baycrest Academy for Research and Education Summer Program in Aging (SPA):加强研究能力,培养同理心,建立跨专业网络和技能,并促进下一代医疗保健工作者的创新
  • 批准号:
    498310
  • 财政年份:
    2024
  • 资助金额:
    $ 9.34万
  • 项目类别:
    Operating Grants
関節リウマチ患者のSuccessful Agingに向けたフレイル予防対策の構築
类风湿性关节炎患者成功老龄化的衰弱预防措施的建立
  • 批准号:
    23K20339
  • 财政年份:
    2024
  • 资助金额:
    $ 9.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Life course pathways in healthy aging and wellbeing
健康老龄化和福祉的生命历程路径
  • 批准号:
    2740736
  • 财政年份:
    2024
  • 资助金额:
    $ 9.34万
  • 项目类别:
    Studentship
I-Corps: Aging in Place with Artificial Intelligence-Powered Augmented Reality
I-Corps:利用人工智能驱动的增强现实实现原地老龄化
  • 批准号:
    2406592
  • 财政年份:
    2024
  • 资助金额:
    $ 9.34万
  • 项目类别:
    Standard Grant
NSF PRFB FY 2023: Connecting physiological and cellular aging to individual quality in a long-lived free-living mammal.
NSF PRFB 2023 财年:将生理和细胞衰老与长寿自由生活哺乳动物的个体质量联系起来。
  • 批准号:
    2305890
  • 财政年份:
    2024
  • 资助金额:
    $ 9.34万
  • 项目类别:
    Fellowship Award
虚弱高齢者のSuccessful Agingを支える地域課題分析指標と手法の確立
建立区域问题分析指标和方法,支持体弱老年人成功老龄化
  • 批准号:
    23K20355
  • 财政年份:
    2024
  • 资助金额:
    $ 9.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
「ケア期間」に着目したbiological aging指標の開発
开发聚焦“护理期”的生物衰老指数
  • 批准号:
    23K24782
  • 财政年份:
    2024
  • 资助金额:
    $ 9.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了